CD274 and non-small cell lung carcinoma: These authors found that the outcome of ICI therapy in patients with non-small cell lung carcinoma (NSCLC), who were treated with antibiotics in the period directly before programmed death 1 (PD-1)/PD-L1 targeted ICI therapy, was significantly poorer than in patients not treated with antibiotics [7].